Toronto police and the family of the billionaire couple who were found dead in their Toronto mansion have released a joint statement on the couple’s deaths.
At a press conference Monday morning, TPS’ head of homicide, Hank Idsinga, said investigators have obtained 38 judicial authorizations, which have resulted in the searches of residential and commercial properties, electronic devices, and the production of 73 individual records.
One hundred and fifty items have been submitted to the Centre of Forensic Science for testing, 243 witnesses have been interviewed, and four terabytes of security video have been obtained.
Idsinga also said police have received 205 tips directly from the public related to their investigation into the “targeted double homicide” of the Shermans and 343 tips have been provided to the police via the private investigative team.
To date, 701 investigative actions have been assigned, according to Idsinga.
- See also:
However, despite this, police said their investigation is still active and ongoing and they are asking for help.
The family and investigators are urging anyone with reliable information regarding the murders — no matter how small or unimportant that information may seem — to contact the police.
The Sherman family is still offering a $10-million reward for information that leads to the arrest and conviction of the couple’s killer or killers.
According to police, on December 15, at 11:44 am, officers responded to a call at 50 Old Colony Road in North York, where investigators discovered the Shermans deceased, with belts around their necks attached to a railing near their indoor pool.
Police said post-mortem examinations were carried out and the cause of death for both victims was ligature neck compression, meaning strangulation.
The Shermans were last seen alive on Wednesday, December 13, and made no contact with family or friends.
Barry Sherman is the founder of Canadian pharmaceutical giant Apotex, and according to Forbes, Sherman was one of Canada’s billionaires, with Apotex’s medicines filling over 89 million prescriptions a year in Canada alone, and annual global revenues of $1.5 billion.